Diabetes
Latest News
Can Response to Semaglutide Be Predicted With a Genetic Test?
AI genetic testing may help identify patients who would benefit from semaglutide, by identifying abnormal postprandial satiety.
Latest News
GLP-1 Thyroid Warning Could Increase Overdiagnosis
A boxed warning about thyroid cancer risk with GLP-1s could lead to unnecessary screening, expert says.
Commentary
Facial Temperature Can Reveal Age and Disease
Research points to use of facial temperature to determine age, health, diet, and sleep, says physician.
Latest News
What Should Be Prioritized in Managing Early Diabetes?
ADA meeting debate on what to treat first in early diabetes included obesity, glucose, remission as priorities.
Latest News
Triple Therapy May Be Effective in Drug-Naive T2D
Combo of metformin, dapagliflozin, and saxagliptin could reduce body weight and adverse events, compared with step-wise therapy.
Latest News
Exercise Plus GLP-1 RAs Upped Weight Loss, Bone Retention
Study finds combination of GLP-1 RAs and exercise increased weight loss and maintained bone health.
Latest News
Does Semaglutide Reduce Inflammation?
Study finds an association between semaglutide and reduced inflammatory marker levels; implications are yet unknown.
Latest News
Pancreatic Gene Therapy: A ‘One-and-Done’ GLP-1 Treatment?
A single-dose pancreatic gene therapy may compare with GLP-1 effect, a mouse model study finds.
Latest News
Compounded Semaglutide: How to Better Ensure Its Safety
Ask questions about the pharmacy and, if possible, interview the pharmacist about certifications and procedures.
Latest News
Diabetic Foot Infections: A Peptide’s Potential Promise
Microbial eradication rates were notably better in the PL-5 group and clearance rates of drug-resistant bacteria were also higher.
Latest News
Ghrelin Paradox: Unlocking New Avenues in Obesity Management
The hunger hormone’s role in appetite and weight gain may be an option for weight management as researchers look to therapeutic modulation.